1. The Tenth Decimal

The error occurred on a Thursday.

It was the kind of Thursday that tasted of stale coffee and fluorescent light, the air inside the Borealis Pharmaceutical quality control laboratory thick with the hum of spectrometers and the occasional clink of glass vials. Maren Eklund sat at her workstation, a beige terminal glowing with columns of numbers that had begun to blur together sometime around eleven in the morning. She had been running batch analyses on imported glycerin since six, and her eyes felt like they had been rubbed with sandpaper.

The sample in question arrived in a small amber bottle labeled GV-4472, shipped from a supplier in the southern trade zone. Glycerin was inert, harmless, a sweetening agent used in pediatric cough syrups to mask the bitterness of active ingredients. Nobody worried about glycerin. That was why the testing protocol had grown slack over the years, reduced from three verification passes to a single technician's sign-off, a cost-saving measure implemented by a regional manager whose name Maren had already forgotten.

She entered the viscosity reading: 1.248. She checked it against the reference range, blinked, and typed the final value into the purity field. The decimal point slipped one position to the left. The system accepted the entry without protest. The batch passed.

Maren did not notice for another four hours.

At forty-three, Maren had worked at Borealis for eleven years, long enough to have watched the plant shrink from a bustling facility of two hundred workers to a skeleton crew of sixty-three. The cafeteria had closed two winters ago. The break room still had a coffee machine, but it dispensed a thin brown liquid that tasted vaguely of burnt plastic. She had stayed because the pay was steady and because her mother, bedridden in a care home in the northern province of Kelmfjord, needed monthly payments that no other job in the region could cover.

She discovered the error at three-seventeen in the afternoon, when the afternoon shift supervisor asked her to spot-check a random sample from the morning's batch run. Maren pulled up her original entries and felt her stomach drop. The decimal was wrong. The viscosity reading had been 1.248, but the acceptable ceiling for pharmaceutical-grade glycerin was 1.240. At 1.248, the sample was out of spec. Worse, that particular viscosity profile was consistent with industrial-grade glycerin contaminated with diethylene glycol—a compound used in antifreeze and brake fluid, a slow-acting renal toxin that had been responsible for multiple mass poisoning events across the continent over the past century.

She stared at the screen for a long time.

The batch had already been approved for production. By now, the glycerin would be mixed into the base syrup, and the base syrup would be flowing into the filling lines, and the filling lines would be spitting out bottles of Febrisol, a cherry-flavored pediatric cough remedy destined for pharmacies across the coastal districts.

Maren calculated the odds. The contamination threshold was borderline; at 1.248, the diethylene glycol concentration might be low enough to cause nothing worse than mild nausea. Children metabolized quickly. Perhaps nothing would happen. Perhaps no one would ever know.

She closed the file.

She did not correct the entry. She did not flag the batch number. She shut down her terminal, collected her coat from the hook by the locker room, and walked out into the gray Valdorian winter afternoon. The air smelled of salt and diesel from the harbor three kilometers away. She boarded the number 17 bus and sat in the back, watching the pharmaceutical plant recede through a rain-streaked window, telling herself that the silence was temporary, that she would report it tomorrow, that one day's delay would not matter.

The bus trundled through the outskirts of Hvidhavn, a coastal town of steep-roofed houses and narrow cobblestone streets that wound down toward a slate-colored sea. The town had once been a fishing village, but the fishing had declined, and now it subsisted on tourism in summer and a quiet, dignified decay through the long dark months. The streetlights flickered on as the bus passed the old customs house, their orange glow reflecting in puddles that had formed between the cobblestones.

Maren got off at Linden Street and walked three blocks to her apartment, a one-room unit above a shuttered bakery. She unlocked the door, hung her coat, and stood in the dark for a full minute before switching on the light. On the kitchen table sat a photograph of her mother, a ceramic mug holding a single dried thistle, and a stack of unpaid care home invoices.

She did not sleep that night.

The next morning, a Friday, Dr. Elias Voss opened his clinic at half past seven.

The clinic occupied the ground floor of a converted merchant's house on Harbor Street, its waiting room furnished with wooden benches that had been polished smooth by decades of anxious parents. The walls displayed anatomical charts of the respiratory system and a framed diploma from the University of Lundström. A small ceramic owl—a gift from a patient who had recovered from pneumonia twenty years ago—stood on the reception desk, its painted eyes watching the door.

Elias was fifty-seven, a widower with silver hair cropped short and hands that had not trembled in forty years of practice. His wife, Ingrid, had died of pancreatic cancer six years earlier, and since then he had lived alone in a small house at the edge of town, tending a garden that produced more weeds than vegetables and reading detective novels that he never finished. He had no children. His patients were his children, all two thousand of them registered across three coastal districts, and he knew most of them by name, by the sound of their coughs, by the worried expressions their parents wore when they pushed through the clinic door.

At nine-forty, Klara Lindqvist brought her daughter Linnea to see him.

Linnea was seven years old, a slight girl with hair the color of winter wheat and eyes that were perpetually curious, as if the world were a puzzle she intended to solve. She had been running a low-grade fever for three days, accompanied by a dry cough that worsened at night. Klara, a widow who ran the Book Nook on Canal Street, had tried honey tea and steam baths and a tincture of elderberry from the herbalist on Quay Road. Nothing had helped.

"Sit up here, little bird," Elias said, patting the examination table.

Linnea climbed up, her legs dangling over the edge. She wore a green sweater with a reindeer pattern and carried a small stuffed rabbit with one missing button eye. Elias listened to her chest with his stethoscope, frowning slightly at the faint wheeze in the lower right lobe. He checked her throat, her ears, her temperature.

"Nothing serious," he told Klara, who stood with her arms crossed tight against her chest, her face drawn with the particular exhaustion of a mother who had not slept in three nights. "A bronchial irritation. I'll prescribe something for the cough so she can rest."

He wrote the prescription on a small pad: Febrisol syrup, one teaspoon before bed, for five days. He had been prescribing Febrisol for fifteen years. It was manufactured by Borealis, a reputable Valdorian company, and he had never received a single complaint about its efficacy or safety.

"Thank you, Dr. Voss," Klara said. She managed a tired smile, the kind that did not reach the eyes. "I'm sorry to bother you with something so small."

"Nothing is small when it comes to children," Elias replied, and the words were automatic, a phrase he had spoken thousands of times, but he meant them.

Linnea hopped off the table and clutched her rabbit. "Can I have a sticker?" she asked.

Elias opened the drawer where he kept a sheet of adhesive stars and let her choose a silver one. She pressed it carefully onto her rabbit's ear and beamed.

They left. The door chimed. The little ceramic owl watched them go.

Three blocks away, Rasmus Falk stood behind the counter of the Crown Pharmacy, counting pills into a small amber bottle.

Rasmus was sixty-one, a heavyset man with a careful manner and a mustache that had gone entirely gray. He had owned the Crown Pharmacy for thirty-two years, inheriting it from his father, who had inherited it from his father before him. The shop was a narrow, high-ceilinged space lined with dark wooden shelves that held jars of dried herbs, bottles of tincture, and the modern pharmaceuticals that had gradually displaced the old remedies. The air smelled of licorice root and camphor and something else, something chemical and faintly sweet that no amount of ventilation could entirely disperse.

He filled Klara's prescription at eleven-twenty that morning.

The Febrisol bottles had arrived the previous afternoon, packed in a cardboard box bearing the Borealis logo. Rasmus unpacked them himself, as he unpacked all new stock, checking the batch numbers against the delivery manifest out of a habit formed decades ago when a counterfeit shipment of heart medication had reached the neighboring town of Sölvik and killed two elderly patients. The batch number matched. The seals were intact. The expiration date was nineteen months out.

He dispensed a single bottle to Klara Lindqvist, who paid with a worn banknote and thanked him in a voice that barely rose above a whisper. Rasmus watched her leave, the bell above the door jangling, and felt a brief prickle of something that he could not name. He dismissed it as indigestion and went back to counting pills.

What he did not tell anyone—what he had never told anyone—was that he recognized the supplier codes on the Borealis manifest. The glycerin used in this batch had been sourced from a trading company that Rasmus had investigated twelve years earlier, during his brief and disastrous tenure on the regional pharmaceutical ethics committee. That company, Ember Trade & Logistics, had been flagged for importing industrial-grade glycerin from unregulated refineries in the southern territories and relabeling it for pharmaceutical use. The investigation had been quietly dropped after a series of closed-door meetings involving a Borealis executive, a health ministry undersecretary, and a sum of money large enough to buy a house in the capital.

Rasmus had been paid off, too. Not with cash. His payment had been a scholarship for his son, Jens, to attend the prestigious Sölgaard Academy, a gift arranged by a Borealis liaison who had visited his office one rainy afternoon and made it clear that the scholarship was contingent on Rasmus's continued discretion. Jens had gone on to study journalism at the University of Lundström. He was now twenty-nine, working for an independent news outlet in the capital, writing investigative pieces about corruption in the fishing industry and pharmaceutical pricing. He did not know about the scholarship's provenance. Rasmus intended to keep it that way.

When Klara's prescription passed across his counter, Rasmus did not check the batch number against his old records. He did not call the ethics committee. He did not alert the health ministry.

He filled the prescription, accepted payment, and turned to the next customer.

By Sunday, Linnea was worse.

The cough had deepened, rattling in her chest like loose stones. Her fever spiked to thirty-nine degrees, and she complained of pain in her lower back, a dull ache that made her cry when Klara tried to lift her from the bed. Klara called the clinic at six in the evening, but the answering service informed her that Dr. Voss was making house calls in the northern district and would not be available until morning.

"Take her to the hospital in Sölvik," the dispatcher said. "If it's urgent."

Klara hesitated. The hospital in Sölvik was forty kilometers away, and she did not own a car. The last bus had already departed. She could call a taxi, but the fare would deplete the small emergency fund she kept in a tin beneath the kitchen sink. She decided to wait.

At midnight, Linnea stopped urinating.

Klara found a neighbor with a car, a retired fisherman named Otto who lived two doors down and kept a battered sedan in his garage. He drove them through the rain to Sölvik Regional Hospital, the windshield wipers beating a frantic rhythm against the glass while Klara held Linnea in the back seat, whispering reassurances that the child was too far gone to hear.

The emergency room physician, a young woman named Dr. Sørensen, ran blood tests and started an IV line. At three in the morning, she pulled Klara into a small consultation room with beige walls and a plastic chair and told her that Linnea's kidneys were failing. The cause was unclear, but the toxicology screen had flagged something unusual: elevated levels of diethylene glycol metabolites.

"Has she ingested any antifreeze?" Dr. Sørensen asked. "Brake fluid? Any household chemicals?"

"No," Klara said. "No, she's seven. She doesn't—she wouldn't—"

"The cough syrup," Dr. Sørensen said. "Do you have the bottle?"

Klara had the bottle. She had brought it in her bag, intending to ask the doctor if she should continue the dosage. She handed it over with trembling hands.

Dr. Sørensen examined the label, the batch number, the manufacturing date. Her face went very still.

"I need to make some calls," she said.

Elias received the call at five-thirty Monday morning.

He had been up since four, unable to sleep, troubled by a dream he could not remember. When the phone rang, he was sitting at his kitchen table with a cup of cold coffee and a half-read detective novel, watching the first gray light seep through the curtains.

"Dr. Voss," said the voice on the line, a health ministry official whose name Elias did not catch, "we need to ask you about a prescription you wrote on Friday."

The official told him about Linnea. About the diethylene glycol. About the batch of Febrisol that had been flagged by the Sölvik toxicology lab.

Elias listened in silence, the phone pressed against his ear, his free hand resting motionless on the open page of his novel. When the official finished speaking, Elias asked one question: "Will she live?"

A pause. "It's too early to say."

Elias hung up and sat very still for a long time. The sun rose over the harbor, painting the water in shades of rose and gold. The fishermen were already out, their boats small dark shapes against the glittering expanse. He thought about Linnea's silver star sticker, pressed carefully onto her rabbit's ear. He thought about the seven years he had known her, the ear infections and scraped knees and the time she had swallowed a button and he had fished it out with a pair of forceps while she giggled at the absurdity of it all.

He thought about the prescription he had written, the letters formed by his own hand, the signature at the bottom that authorized the dispensing of poison.

Then he put on his coat and walked to the clinic, where the health ministry investigators were already waiting.

Two hundred kilometers away, at a desk in the capital city of Lundström, Sigrid Möller pressed "send" on an encrypted message.

Sigrid was a data analyst for the National Medicines Regulatory Authority, a quiet woman of thirty-four with sharp cheekbones and a limp from a childhood bout of polio. For the past eighteen months, she had been compiling a dossier on Borealis Pharmaceutical, documenting cost-cutting measures, falsified quality control reports, and the systematic intimidation of internal whistleblowers. Her file contained internal memos, toxicology results, and a deposition from a former Borealis chemist who had fled to a neighboring country after attempting to flag a contaminated glycerin shipment three years earlier.

The dossier was almost complete. It needed one more piece: a direct link between Borealis executives and the decision to override the purity rejection of batch GV-4472.

Sigrid had a contact inside the Borealis plant, a quality control technician who had reached out through an anonymous tip line six months ago, offering information in exchange for protection. They had been communicating through dead drops and encrypted channels, slowly building the case. The technician's latest message had arrived the previous evening: she was ready to provide the final documents, the internal logs that would prove the contamination had been detected and deliberately ignored.

Sigrid scheduled a meeting for Wednesday, in a café near the harbor in Hvidhavn.

She did not know the technician's name. She did not know that the technician had spent the past four nights staring at a flickering terminal screen, paralyzed by the realization that her silence had already killed one child and might kill more. She did not know that the technician was planning to confess everything—not just the Borealis documents, but her own complicity, her own cowardice, her own unforgivable decimal point.

Sigrid pressed send. The message vanished into the encrypted void.

She leaned back in her chair, rubbing her stiff leg, and allowed herself a small, cautious hope. The dossier would be complete. The health ministry would be forced to act. The guilty would be held accountable.

She did not know that Borealis security had flagged her encrypted channel two weeks earlier. She did not know that a fixer named Viktor Aalto, a former military intelligence officer with a specialization in industrial counter-espionage, had been dispatched to Hvidhavn with instructions to contain the leak by any means necessary.

She did not know that the meeting she had just scheduled would never take place.

And in her apartment above the shuttered bakery on Linden Street, Maren Eklund sat in the dark, staring at the photograph of her mother, waiting for the courage to come.